DCGI has suspended phase 2 and 3 clinical trials

The Drugs Controller General of India (DCGI) ordered the Serum Institute of India for suspending phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine. The candidates of AstraZeneca have paused the trials in other countries. Dr VG Somani of DCGI ordered the Serum Institute of India (SII) to raise the safety measures of the people who are already vaccinated.